Betsy S. Atkins, a director at Enovix Corp (NASDAQ:), has recently sold a significant portion of her holdings in the company. According to a recent filing, Atkins sold 75,000 shares of Enovix common stock on December 3, 2024. The shares were sold at a weighted-average price of $9.73, resulting in a total transaction value of approximately $729,750. The transaction occurred as the stock, which currently trades at $10.07, shows significant volatility according to InvestingPro data. The company maintains a strong liquidity position with a current ratio of 3.77.
The sale was conducted under a Rule 10b5-1 trading plan, which Atkins had adopted on August 29, 2023. Following this transaction, Atkins retains ownership of 99,497 shares, which includes 11,346 shares issuable upon the settlement of restricted stock units. With a market capitalization of $1.91 billion, Enovix has attracted strong analyst interest, maintaining a bullish consensus recommendation of 1.46 on a scale where 1 represents a “Strong Buy.”
The shares were sold in multiple transactions at prices ranging from $9.54 to $10.02. Atkins has committed to providing detailed information about the number of shares sold at each price upon request. For deeper insights into Enovix’s valuation and comprehensive insider trading patterns, InvestingPro subscribers can access detailed financial health metrics and expert analysis in the Pro Research Report, available for over 1,400 US stocks.
In other recent news, Enovix Corporation has been making notable strides in its business operations. The company reported a 13% sequential increase in its third-quarter revenue, reaching $4.3 million. This was revealed during the company’s earnings call, alongside the announcement of a new manufacturing facility in Malaysia, and a significant agreement with a leading smartphone OEM.
Enovix has also appointed Dr. Hongwei Yan as its new Chief Technology Officer. Dr. Yan’s extensive experience in material science innovation and commercialization is expected to enhance the company’s market share growth. His appointment is seen as a strategic move to transform material science innovations into commercially viable products more effectively.
Despite a non-GAAP EBITDA loss of $21.6 million for the quarter, Enovix maintains a strong cash position and projects Q4 revenue between $8 million and $10 million. The company is collaborating with Group14 for anode materials and multiple suppliers for battery production. Looking ahead, Enovix has plans for a production and sales ramp-up in late 2025, and is considering entry into the IoT market.
These are recent developments that highlight the company’s ongoing efforts to strengthen its position in the market. Enovix’s shares have retained an Outperform rating with a steady price target of $36.00, reflecting a positive outlook on the company’s future performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
